Methods and compositions for modulating hepatocyte growth factor activation

Details for Australian Patent Application No. 2005269463 (hide)

Owner Genentech, Inc.

Inventors Peek, Mark D.; Kirchhofer, Daniel K.; Moran, Paul M.

Agent Griffith Hack

Pub. Number AU-B-2005269463

PCT Pub. Number WO2006/014928

Priority 60/591,339 26.07.04 US

Filing date 25 July 2005

Wipo publication date 9 February 2006

Acceptance publication date 18 August 2011

International Classifications

C12Q 1/37 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving peptidase or proteinase

G01N 33/74 (2006.01) Investigating or analysing materials by specific methods not covered by groups - involving hormones

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/014928 Priority application(s): WO2006/014928

18 August 2011 Application Accepted

  Published as AU-B-2005269463

15 December 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005269465-Treatment of pulmonary hypertension by inhaled iloprost with a microparticle formulation

2005269462-Stabilized pancreas product